Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2024 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: A.J. Mullen who wrote (76)	5/23/2024 4:05:07 PM
From: technetium	Read Replies (1) \| Respond to of 195

I recently watched a short webinar from ILMN Illumina, featuring how far they have progressed when it comes to genome sequencing. They can now do 64 genomes a day for a few cents a base. A combination of leaps and bounds in genome sequencing capability and the drastic reduction in the price of computer data storage costs and increased computing speed. Pretty astonishing. Also discussed how lyophilization helps stabilize the DNA sample and makes it easier to get accurate data. illumina.com I don’t own the stock.